Senores Pharmaceuticals Ltd's initial public offering (IPO), worth ₹582 crore, witnessed an extraordinary response from investors, achieving an astounding 93.69-times subscription on its final bidd
Senores Pharmaceuticals Ltd, an Ahmedabad-based pharmaceutical firm, announced that it raised nearly Rs 261 crore from anchor investors before the public subscription of its initial public offering
Granules India announced on Tuesday that its US subsidiary, Granules Pharmaceuticals, Inc (GPI), has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug
Geojit Financial Services has reaffirmed its BUY recommendation for Cipla Ltd., assigning a revised target price of Rs. 1,695. This valuation is based on a 26x FY26E adjusted EPS.